ARCHIVES

Ovarian Suppression Treatment Plus Tamoxifen Can Lower Recurrence Risk

This article is from The Cancer Letter archive.

Vol. 37 No. 12 | December 26, 2014

Download PDF Visit The Full Archive

Related Articles

DCT Board Okays Contract Recompetitions, But Litton Bionetics May Be Barred From Two Supporting Gall’s Lab, Plus FCRF Program

October 25, 1985

Haller Named Editor-In-Chief Of JCO; White House Appoints Duffy To NCAB.

March 17, 2000

NCI Outlines Need For $3,873 Billion To Seize Cancer Research Opportunities

October 30, 1998

In Congress: Senate Resolution Includes $15 Billion For NIH In FY99

April 10, 1998

Reagan Goes On Record Against Smoking, Dietary Fat

April 22, 1988

Capitol Hill: Advocates Lobby Congress To Close Medicare Loophole For Colonoscopy Coverage

July 18, 2014